Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study
Abstract
1998, a consensus meeting was held in Miyazaki, Japan, to develop an approach to management of febrile neutropenia (FN). The K-HOT study group decided to examine whether this proposal was applicable to clinical practice in a multicenter study. Patients who developed fever with neutrophil counts < …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
algorithms
adult
female
male
Drug Administration Schedule
Comparative Study
Clinical Trial
Multicenter Study
controlled clinical trial
drug therapy
neutropenia / drug therapy*
fever / etiology*
neutropenia / etiology
anti-bacterial agents / therapeutic use*
combination / therapeutic use*
cephalosporins / therapeutic use*
aminoglycosides
cefepime
pmid:12447952
doi:10.1002/ajh.10236
k tamura
h matsuoka
kyushu hematology organization for treatment (k-hot) study group
carbapenems / administration & dosage
carbapenems / therapeutic use*
cephalosporins / administration & dosage
leukemia / physiopathology
lymphoma / physiopathology
Access
Citation
ID:
117717
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
117717
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
